Literature DB >> 18606709

Cigarette smoke-induced oxidative stress suppresses generation of dendritic cell IL-12 and IL-23 through ERK-dependent pathways.

Paula R Kroening1, Terrance W Barnes, Larry Pease, Andrew Limper, Hirohito Kita, Robert Vassallo.   

Abstract

IL-12p70, a heterodimer composed of p35 and p40 subunits, is a key polarizing cytokine produced by maturing dendritic cells (DCs). We report that cigarette smoke extract (CSE), an extract of soluble cigarette smoke components, suppresses both p35 and p40 production by LPS or CD40L-matured DCs. Suppression of IL-12p70 production from maturing DCs was not observed in the presence of nicotine concentrations achievable in CSE or in the circulation of smokers. The suppressed IL-12p70 protein production by CSE-conditioned DCs was restored by pretreatment of DCs or CSE with the antioxidants N-acetylcysteine and catalase. Inhibition of DC IL-12p70 by CSE required activation of ERK-dependent pathways, since inhibition of ERK abrogated the suppressive effect of CSE on IL-12 secretion. Oxidative stress and sustained ERK phosphorylation by CSE enhanced nuclear levels of the p40 transcriptional repressor c-fos in both immature and maturing DCs. Suppression of the p40 subunit by CSE also resulted in diminished production of IL-23 protein by maturing DCs. Using a murine model of chronic cigarette smoke exposure, we observed that systemic and lung DCs from mice "smokers" produced significantly less IL-12p70 and p40 protein upon maturation. This inhibitory effect was selective, since production of TNF-alpha during DC maturation was enhanced in the smokers. These data imply that oxidative stress generated by cigarette smoke exposure suppresses the generation of key cytokines by maturing DCs through the activation of ERK-dependent pathways. Some of the cigarette smoke-induced inhibitory effects on DC function may be mitigated by antioxidants.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18606709      PMCID: PMC2819390          DOI: 10.4049/jimmunol.181.2.1536

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  59 in total

1.  Pulmonary interleukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs.

Authors:  Kyle I Happel; Euan A Lockhart; Carol M Mason; Elizabeth Porretta; Elizabeth Keoshkerian; Anthony R Odden; Steve Nelson; Alistair J Ramsay
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming.

Authors:  Robert Vassallo; Koji Tamada; Julie S Lau; Paula R Kroening; Lieping Chen
Journal:  J Immunol       Date:  2005-08-15       Impact factor: 5.422

3.  Reactive oxygen species activate human peripheral blood dendritic cells.

Authors:  K Rutault; C Alderman; B M Chain; D R Katz
Journal:  Free Radic Biol Med       Date:  1999-01       Impact factor: 7.376

4.  Association between smoking and tuberculosis infection: a population survey in a high tuberculosis incidence area.

Authors:  S den Boon; S W P van Lill; M W Borgdorff; S Verver; E D Bateman; C J Lombard; D A Enarson; N Beyers
Journal:  Thorax       Date:  2005-07       Impact factor: 9.139

5.  IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available.

Authors:  Shabaana A Khader; John E Pearl; Kaori Sakamoto; Leigh Gilmartin; Guy K Bell; Dawn M Jelley-Gibbs; Nico Ghilardi; Fred deSauvage; Andrea M Cooper
Journal:  J Immunol       Date:  2005-07-15       Impact factor: 5.422

6.  Oxidized beta2-glycoprotein I induces human dendritic cell maturation and promotes a T helper type 1 response.

Authors:  Brigitta Buttari; Elisabetta Profumo; Vincenzo Mattei; Alessandra Siracusano; Elena Ortona; Paola Margutti; Bruno Salvati; Maurizio Sorice; Rachele Riganò
Journal:  Blood       Date:  2005-08-11       Impact factor: 22.113

7.  Clinical and epidemiological aspects of smoking and tuberculosis: a study of 13,038 cases.

Authors:  M N Altet-Gômez; J Alcaide; P Godoy; M A Romero; I Hernández del Rey
Journal:  Int J Tuberc Lung Dis       Date:  2005-04       Impact factor: 2.373

8.  Acrolein in cigarette smoke inhibits T-cell responses.

Authors:  Cherie Lambert; Jesica McCue; Mary Portas; Yanli Ouyang; JiMei Li; Thomas G Rosano; Alexander Lazis; Brian M Freed
Journal:  J Allergy Clin Immunol       Date:  2005-08-01       Impact factor: 10.793

9.  Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae.

Authors:  Kyle I Happel; Patricia J Dubin; Mingquan Zheng; Nico Ghilardi; Christie Lockhart; Lee J Quinton; Anthony R Odden; Judd E Shellito; Gregory J Bagby; Steve Nelson; Jay K Kolls
Journal:  J Exp Med       Date:  2005-09-12       Impact factor: 14.307

10.  Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway.

Authors:  Refaat A F Hegazi; Kavitha N Rao; Aqila Mayle; Antonia R Sepulveda; Leo E Otterbein; Scott E Plevy
Journal:  J Exp Med       Date:  2005-12-19       Impact factor: 14.307

View more
  44 in total

Review 1.  Programming dendritic cells to induce T(H)2 and tolerogenic responses.

Authors:  Bali Pulendran; Hua Tang; Santhakumar Manicassamy
Journal:  Nat Immunol       Date:  2010-07-20       Impact factor: 25.606

2.  Exposure to cigarette smoke inhibits the pulmonary T-cell response to influenza virus and Mycobacterium tuberculosis.

Authors:  Yan Feng; Ying Kong; Peter F Barnes; Fang-Fang Huang; Peter Klucar; Xisheng Wang; Buka Samten; Mayami Sengupta; Bruce Machona; Ruben Donis; Amy R Tvinnereim; Homayoun Shams
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

Review 3.  How cigarette smoke skews immune responses to promote infection, lung disease and cancer.

Authors:  Martin R Stämpfli; Gary P Anderson
Journal:  Nat Rev Immunol       Date:  2009-05       Impact factor: 53.106

4.  The tobacco smoke component, acrolein, suppresses innate macrophage responses by direct alkylation of c-Jun N-terminal kinase.

Authors:  Milena Hristova; Page C Spiess; David I Kasahara; Matthew J Randall; Bin Deng; Albert van der Vliet
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01       Impact factor: 6.914

Review 5.  Cigarette smoking and inflammation: cellular and molecular mechanisms.

Authors:  J Lee; V Taneja; R Vassallo
Journal:  J Dent Res       Date:  2011-08-29       Impact factor: 6.116

6.  Activation of the UPR protects against cigarette smoke-induced RPE apoptosis through up-regulation of Nrf2.

Authors:  Chuangxin Huang; Joshua J Wang; Jacey H Ma; Chenjin Jin; Qiang Yu; Sarah X Zhang
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

7.  Cellular and humoral immunity in arthritis are profoundly influenced by the interaction between cigarette smoke effects and host HLA-DR and DQ genes.

Authors:  Robert Vassallo; David Luckey; Marshall Behrens; Benjamin Madden; Harvinder Luthra; Chella David; Veena Taneja
Journal:  Clin Immunol       Date:  2014-02-14       Impact factor: 3.969

8.  Functional Effects of Cigarette Smoke-Induced Changes in Airway Smooth Muscle Mitochondrial Morphology.

Authors:  Bharathi Aravamudan; Michael Thompson; Gary C Sieck; Robert Vassallo; Christina M Pabelick; Y S Prakash
Journal:  J Cell Physiol       Date:  2016-09-21       Impact factor: 6.384

9.  N-acetylcysteine administration is associated with reduced activation of NF-kB and preserves lung dendritic cells function in a zymosan-induced generalized inflammation model.

Authors:  Hong-Wei Wang; Wen Yang; Jiang-Yang Lu; Fei Li; Jun-Zhong Sun; Wen Zhang; Nan-Nan Guo; Lei Gao; Jia-Rui Kang
Journal:  J Clin Immunol       Date:  2012-12-16       Impact factor: 8.317

10.  Cigarette smoke promotes dendritic cell accumulation in COPD; a Lung Tissue Research Consortium study.

Authors:  Robert Vassallo; Paula R Walters; Jeffrey Lamont; Theodore J Kottom; Eunhee S Yi; Andrew H Limper
Journal:  Respir Res       Date:  2010-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.